Delisted
Stopped trading. Last price we have: $29.08 on Jan 1, 2026. Fund positions aren't valued until we confirm what happened.
MERSANA THERAPEUTICS INC
MRSN·59045L106·UQ·Common Stock·Healthcare - Biotechnology-13D/G
MRSN (MERSANA THERAPEUTICS INC) is held by 0 institutional investors as of Q1 2026.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold MRSN.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $5,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $228,547 | 0.0% | +1.50% | 0 | |
Exited | 0(-100.0%) | $1.4M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $31,534 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.1M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.8M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $299,831 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $6,394 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2,980 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $650,722 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $374,788 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $345,656 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3,240 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $926 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1,157 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $248,393 | 0.0% | +1.50% | 0 | |
Exited | 0(-100.0%) | $565,379 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $231 | 0.0% | — | 0 |
Showing 1-20 of 26
1 / 2
MRSNMERSANA THERAPEUTICS INCContinue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Inc416 holders · $299.1B
LLYEli Lilly & Co415 holders · $877.5B
TMOThermo Fisher Scientific Inc400 holders · $151.4B
JNJJohnson & Johnson397 holders · $414.1B
DHRDanaher Corp394 holders · $97.5B
ISRGIntuitive Surgical Inc393 holders · $111.5B
MRKMerck & Co Inc390 holders · $230.1B
ABBVAbbVie Inc385 holders · $302.9B
BSXBoston Scientific Corp385 holders · $51.8B
ABTAbbott Laboratories382 holders · $113.8B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer